Levodopa/Carbidopa/Entacapon Macleods

Levodopa, carbidopa, entacapone, the active ingredients in Levodopa/Carbidopa/Entacapon Macleods, are a combination product presented as oral tablets for oral use. They are prescribed to manage Parkinson's disease by improving dopaminergic neurotransmission in patients with motor symptoms.

GNH USA supplies Levodopa/Carbidopa/Entacapon Macleods as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable global distribution.

Levodopa/Carbidopa/Entacapone is used within the dopaminergic pathway to manage Parkinson's disease.

- Parkinson's disease: improves motor symptoms such as bradykinesia, rigidity, and tremor. - Parkinson's disease with motor fluctuations: extends the duration of levodopa effect and reduces OFF periods. - Early-stage Parkinson's disease: delays the need for higher levodopa doses and helps maintain functional independence.

Adverse reactions may occur with Levodopa/Carbidopa/Entacapone therapy.

Common Side Effects: - Nausea: mild to moderate gastrointestinal upset. - Dizziness: often related to orthostatic changes. - Headache: transient and usually resolves. - Insomnia: difficulty falling or staying asleep.

Serious or Rare Side Effects: - Dyskinesia: involuntary, erratic movements. - Hallucinations: visual or auditory disturbances. - Severe hypotension: marked drop in blood pressure, potentially causing fainting.

Use of Levodopa/Carbidopa/Entacapone requires careful clinical monitoring.

- Renal impairment: monitor renal function and adjust therapy if needed. - Hepatic impairment: use with caution; liver function should be assessed. - Cardiovascular disease: observe blood pressure for orthostatic changes. - Psychiatric history: watch for emergence of hallucinations or confusion. - Concomitant MAO‑B inhibitors: avoid unless levodopa dose is reduced. - Store at ambient temperature: keep in the original pack, protect from moisture.

Levodopa/Carbidopa/Entacapone can interact with several medicines.

Major Interactions (Avoid): - Non‑selective MAO inhibitors: risk of hypertensive crisis. - Antipsychotics (dopamine antagonists): may diminish therapeutic effect. - Anticholinergics: can mask motor symptom changes.

Moderate Interactions (Monitor Closely): - Antihypertensives: may enhance hypotensive response. - SSRIs/SNRIs: potential for serotonin syndrome. - Iron or calcium supplements: reduce levodopa absorption; separate dosing by at least 2 hours.